``Recurring Revenue Begins for GeneLink'': A Web Radio Series Featuring Interviews With CEOs, by IPOdesktop.com.Business Editors LOS LOS Length of stay, see there ANGELES--(BUSINESS WIRE)--Nov. 20, 2002 IPOdesktop.com presents "Recurring re·cur intr.v. re·curred, re·cur·ring, re·curs 1. To happen, come up, or show up again or repeatedly. 2. To return to one's attention or memory. 3. To return in thought or discourse. revenue begins for GeneLink," a web radio show with John R. DePhillipo, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of GeneLink (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :GNLK). GNLK has developed a proprietary method for genetic assessments and is beginning to license these breakthrough nutragenetic and dermagenetic profiles to companies that manufacture products for the $100 billion-plus skin care, nutritional nutritional pertaining to or emanating from nutrition. nutritional anemia see nutritional anemia. nutritional assessment supplement, and health care industries. -0-
CEO Guest: John R. DePhillipo, Chairman and CEO of
GeneLink
Show host: Francis Gaskins, Editor, http://IPOdesktop.com
TO LISTEN CLICK: For RealAudio http://gaskinsco.com/gnlk3.ram
Windows Media http://gaskinsco.com/gnlk3.asx
(If these aren't direct links, simply copy and paste to your
Internet browser to listen to the interview)
RADIO SHOW AGENDA
HIGHLIGHTS
-- For the quarter ended September 30, 2002
GNLK initiated shipments to three customers
-- Penetrates the cosmetics and nutrition markets
PRODUCT
GeneLink's patented DNA Collection Kit(R)
APPLICATION - DNA profile assessments
-- By simply swabbing the inside of the mouth
-- Consumers can now enjoy the benefits of a tailored nutritional
or skin care regimen
-- Designed to their individual needs.
REVENUE MODEL
-- Price per test
-- Royalty
SIGNIFICANT PRIOR EVENTS
September 19, 2001 agreement with New York Stock Exchange listed
Arch (ARJ)
-- News article: http://www.bankdna.com/news_articles/09_19_01.asp
-- Arch helps GNLK market to cosmetic companies
July 25, 2002 agreement with MedQuest Pharmacy
-- News article: http://www.bankdna.com/news_articles/07_25_02.asp
-- MedQuest Pharmacy web site: http://www.medquestpharmacy.com
July 15, 2002 agreement with Nugenix
-- News article: http://www.bankdna.com/news_articles/07_15_02.asp
-- Nugenix web site: http://www.nugenix.com
ARCHIVED RADIO SHOWS
-- 'GeneLink CEO Quoted In New York Times Article'
A Web Radio Series Featuring Interviews With CEOs, By
IPOdesktop.com
http://biz.yahoo.com/iw/021007/047293.html (click)
-- GeneLink President Interviewed By IPOdesktop.com's Editor,
Francis Gaskins
http://biz.yahoo.com/iw/020910/046258.html (click)
Forward Looking Statements
http://gaskinsco.com/forwardlooking.htm (click)
About GeneLink http://www.bankdna.com
GeneLink, Inc., a pioneer DNA banking A DNA bank is a repository of DNA, usually used for research or criminal investigation. The NIAS DNA Bank, for example, collects the DNA of agrucultural organisms, such as rice and fish, for scientific research. and hereditary HEREDITARY. That which is inherited. genetic information service company, has developed a proprietary method for genetic assessments (patents pending) and is beginning to license these breakthrough nutragenetic and dermagenetic profiles to companies that manufacture products for the $100 billion-plus skin care, nutritional supplement, and health care industries. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion